Antibody-based techniques for detection of Lyme disease: a challenging issue

References

• Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. Clin Invest. 2004;113(8):1093–1101.
   Google Scholar
• Stanek G, Reiter M. The expanding Lyme Borrelia complex – clinical significance of genomic species? Clin Microbiol Infect. 2011;17(4):487–493.
   PubMed Web of Science ®Google Scholar
• Stanek G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69–79.
   PubMed Web of Science ®Google Scholar
• Halperin JJ, Baker P, Wormser GP. Common misconceptions about Lyme disease. Am J Med. 2013;126(3):264. e1–e7.
   Web of Science ®Google Scholar
• Weinstein A. Editorial commentary: laboratory testing for Lyme disease: time for a change? Clin Infect Dis. 2008;47(2):196–197.
   Google Scholar
• Zajkowska J, Lewczuk P, Strle F, et al. Lyme borreliosis: from pathogenesis to diagnosis and treatment. Clin Dev Immunol. 2012;2012:231657.
   Google Scholar
• Wormser GP, Tang AT, Schimmoeller NR, et al. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa. Med Microbiol Immunol. 2014;203(1):65–71.
   Web of Science ®Google Scholar
• Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484–509.
   PubMed Web of Science ®Google Scholar
• Wang G, Aguero-Rosenfeld M, Wormser GP, et al. Detection of Borrelia burgdorferi. In: Samuels DS, Radolf JD, editors. Borrelia: Molecular Biology, Host Interaction, and Pathogenesis. Norfolk, UK: Caister Academic Press; 2010.
   Google Scholar
• Aguero-Rosenfeld ME. Lyme disease: laboratory issues. Infect Dis Clin North Am. 2008;22(2):301–313.
   PubMed Web of Science ®Google Scholar
• Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127(12):1109–1123.
   PubMed Web of Science ®Google Scholar
• Craven RB, Quan TJ, Bailey RE, et al. Improved serodiagnostic testing for Lyme disease: results of a multicenter serologic evaluation. Emerg Infect Dis. 1996;2(2):136–140.
   Web of Science ®Google Scholar
• Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for Lyme disease. Clin Infect Dis. 2008;47(2):188–195.
   PubMed Web of Science ®Google Scholar
• Brown SL, Hansen SL, Langone JJ. Role of serology in the diagnosis of Lyme disease. JAMA. 1999;282(1):62–66.
   Web of Science ®Google Scholar
• Kaiser R, Rauer S. Advantage of recombinant borrelial proteins for serodiagnosis of neuroborreliosis. J Med Microbiol. 1999;48(1):5–10.
   Web of Science ®Google Scholar
• Kaiser R, Rauer S. Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto. Eur J Clin Microbiol Infect Dis. 1998;17(3):159–166.
   Web of Science ®Google Scholar
• Gajović O, Todorović Z, Nesić L, Lazić Z. [Lyme borreliosis – diagnostic difficulties in interpreting serological results]. Med Pregl. 2010;63(11–12):839–843. Serbian.
   Google Scholar
• Chmielewski T, Tylewska-Wierzbanowska S. Wystepowanie przeciwciał swoistych dla B. burgdorferi u ludzi zdrowych na terenie [Prevalence of Borrelia burgdorferi antibodies in healthy population in Poland]. Przegl Epidemiol. 2002;56(1):33–38. Polish.
   Google Scholar
• Wilske B. Diagnosis of Lyme borreliosis in Europe. Vector Borne Zoonotic Dis. 2003;3(4):215–227.
   PubMed Web of Science ®Google Scholar
• Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49(1):13–21.
   Google Scholar
• Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10–20 years after active Lyme disease. Clin Infect Dis. 2001;33(36):780–785.
   Google Scholar
• Feder HM Jr, Gerber MA, Luger S, Ryan RW. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis. 1992;15(5):788–793.
   Web of Science ®Google Scholar
• Gordis L. Assessing the validity and reliability of diagnostic and screening tests. In: Epidemiology. 2nd ed. Philadelphia, PA, USA: WB Saunders; 2000.
   Google Scholar
• European Concerted Action On Lyme Borreliosis. Available from: http://www.eucalb.com/. Accessed April 4, 2014.
   Google Scholar
• [No authors listed]. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. American College of Physicians. Ann Intern Med. 1997;127(12):1106–1108.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995;44(31):590–591.
   PubMedGoogle Scholar
• Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J Clin Microbiol. 2005;43(8):3602–3609.
   PubMed Web of Science ®Google Scholar
• Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis. 1993; 167(2):392–400.
   Web of Science ®Google Scholar
• Nowakowski J, Schwartz I, Liveris D, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis. 2001;33(12):2023–2027.
   PubMed Web of Science ®Google Scholar
• Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hunfeld KP, Kraiczy P. When to order a Western blot and how to interpret it. Curr Probl Dermatol. 2009;37:169–177.
   Google Scholar
• Steere AC, McHugh G, Damle N, Sikand VK. Prospective study of serologic tests for Lyme disease. Clin Infect Dis. 2008;47(2):188–195.
   PubMed Web of Science ®Google Scholar
• Hunfeld KP, Stanek G, Straube E, et al. Quality of Lyme disease serology. Lessons from the German Proficiency Testing Program 1999–2001. A preliminary report. Wien Klin Wochenschr. 2002 31(13–14):591–600.
   Google Scholar
• Ledue TB, Collins MF, Young J, Schriefer ME. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease. Clin Vaccine Immunol. 2008;15(12):1796–1804.
   Google Scholar
• Zajkowska JM, Kondrusik M, Pancewicz SA, et al. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis]. Pol Merkur Lekarski. 2007;23(134):95–99. Polish.
   Google Scholar
• Peltomaa M, McHugh G, Steere AC. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis. 2003;187(8):1178–1186.
   Web of Science ®Google Scholar
• Zajkowska J, Kondrusik M, Grygorczuk S, et al. The usefulness of ‘in vivo’ antigens in the diagnosis of human Lyme borreliosis. Int J Med Microbiol. 2008;298 Suppl 1:361–364.
   Google Scholar
• Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187(8):1187–1199.
   Web of Science ®Google Scholar
• Branda JA, Aguero-Rosenfeld ME, Ferraro MJ, Johnson BJ, Wormser GP, Steere AC. 2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. Clin Infect Dis. 2010;50(1):20–26.
   Web of Science ®Google Scholar
• Stanek G, Lusa L, Ogrinc K, Markowicz M, Strle F. Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme, neuroborreliosis. Med Microbiol Immunol. 2014;203(2):125–132.
   Web of Science ®Google Scholar
• Zajkowska J, Kondrusik M, Grygorczuk S, et al. Comparison of two types of diagnostic test detecting antibodies against Borrelia burgdorferi: EIA based on one genospecies antigens and ELISA based on recombinant antigens. Przeg Epidemiol. 2006;60 Suppl 1:171–176.
   Google Scholar
• Zajkowska J, Kondrusik M, Pancewicz S, et al. Western-blot with VlsE protein and “in vivo” antigens in Lyme borreliosis diagnosis. Przegl Epidemiol. 2006;60 Suppl 1:177–185.
   Google Scholar
• Sillanpää H, Lahdenne P, Sarvas H, et al. Immune responses to borrelial VlsE IR6 peptide variants. Int J Med Microbiol. 2007;297(1):45–52.
   Web of Science ®Google Scholar
• Luft BJ, Dunn JJ, Dattwyler RJ, Gorgone G, Gorevic PD, Schubach WH. Cross-reactive antigenic domains of the flagellin protein of Borrelia burgdorferi. Res Microbiol. 1993;144(4):251–257.
   Web of Science ®Google Scholar
• Magnarelli LA, Miller JN, Anderson JF, Riviere GF. Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J Clin Microbiol. 1990;28(6):1276–1279.
   Web of Science ®Google Scholar
• Magnarelli LA, Anderson JF. Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi. Am J Epidemiol. 1988;127(4):818–825.
   Web of Science ®Google Scholar
• Henningsson AJ, Christiansson M, Tjernberg I, Löfgren S, Matussek A. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis. November 22, 2013. [Epub ahead of print.]
   Web of Science ®Google Scholar
• Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30(2):197–205.
   Web of Science ®Google Scholar
• Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184(2):101–122.
   PubMed Web of Science ®Google Scholar
• Mygland A, Ljostad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8–16.
   PubMed Web of Science ®Google Scholar
• Blanc F, Jaulhac B, Fleury M, et al. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. Neurology. 2007;69(10):953–958.
   Web of Science ®Google Scholar
• Hammers-Berggren S, Hansen K, Lebech AM, et al. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43(1):169–175.
   Web of Science ®Google Scholar
• Ljøstad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol. 2007; 14(8):873–876.
   Web of Science ®Google Scholar
• Cerar T, Ogrinc K, Cimperman J, Lotric-Furlan S, Strle F, Ruzić-Sabljić E. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol. 2008;46(10):3375–3379.
   PubMed Web of Science ®Google Scholar
• Dunaj J, Moniuszko A, Zajkowska J, Pancewicz S. The role of PCR in diagnostics of Lyme borreliosis. Przegl Epidemiol. 2013;67(1):35–39, 119–123.
   Google Scholar
• Lebech AM, Hansen K, Brandrup F, Clemmensen O, Halkier-Sørensen L. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn. 2000;5(2):139–150.
   PubMedGoogle Scholar